FDA 483 OBSERVATION · #125 OF 1,945 MOST-CITED

Prepared for each batch, include complete information

FDA cited this observation 245 times across 228 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs245
BY FISCAL YEAR
FY202616
FY202521
FY202426
FY202310
FY202222
FY202110
FY202010
FY201934
FY201822
FY201747
FY201627

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 5.6× the rate of the average FDA-cited firm (43.4% vs 7.8%), across 228 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Batch production and control records do not include complete information relating to the production and control of each batch.

Steril-Gene Life Sciences Private Ltd · Puducherry · Drugs · 2026-08-12

Batch production and control records do not include complete information relating to the production and control of each batch.

Hetero Labs Ltd. Unit VI · Mahaboob Nagar · Drugs · 2026-06-26

Batch production and control records do not include complete information relating to the production and control of each batch.

Nowcos Co., Ltd. · Sejong · Drugs · 2026-06-19

Batch production and control records are not prepared for each batch of drug product produced and do not include complete information relating to the production and control of each batch.

Safecor Health, LLC · Columbus, Ohio · Drugs · 2026-06-12

Batch production and control records do not include complete information relating to the production and control of each batch.

Pillar5 Pharma Inc. · Arnprior · Drugs · 2026-06-05

Batch production and control records do not include complete information relating to the production and control of each batch.

Topical Pharmaceuticals, Inc. · Addison, Illinois · Drugs · 2026-05-07

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →